Abstract
Purpose
To prospectively evaluate the feasibility of 3-D radioguided occult lesion localization (iROLL) and to compare iROLL with wire-guided localization (WGL) in patients with early-stage breast cancer undergoing breast-conserving surgery and sentinel lymph node biopsy (SLNB).
Methods
WGL (standard procedure) and iROLL in combination with SLNB were performed in 31 women (mean age 65.1 ± 11.2 years) with early-stage breast cancer and clinically negative axillae. Patient comfort in respect of both methods was assessed using a ten point scale. SLNB and iROLL were guided by freehand SPECT (fhSPECT). The results of the novel 3-D image-based method were compared with those of WGL, ultrasound-based lesion localization, and histopathology.
Results
iROLL successfully detected the malignant primary and at least one sentinel lymph node in 97 % of patients. In a single patient (3 %), only iROLL, and not WGL, enabled lesion localization. The variability between fhSPECT and ultrasound-based depth localization of breast lesions was low (1.2 ± 1.4 mm). Clear margins were achieved in 81 % of the patients; however, precise prediction of clear histopathological surgical margins was not feasible using iROLL. Patients rated iROLL as less painful than WGL with a pain score 0.8 ± 1.2 points (p < 0.01) lower than the score for iROLL.
Conclusion
iROLL is a well-tolerated and feasible technique for localizing early-stage breast cancer in the course of breast-conserving surgery, and is a suitable replacement for WGL. As a single image-based procedure for localization of breast lesions and sentinel nodes, iROLL may improve the entire surgical procedure. However, no advantages of the image-guided procedure were found with regard to prediction of complete tumour resection.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. doi:10.3322/caac.20107.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi:10.3322/caac.21254.
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol. 2005;34:405–12. doi:10.1093/ije/dyh414.
Lovrics PJ, Cornacchi SD, Vora R, Goldsmith CH, Kahnamoui K. Systematic review of radioguided surgery for non-palpable breast cancer. Eur J Surg Oncol. 2011;37:388–97. doi:10.1016/j.ejso.2011.01.018.
Dua SM, Gray RJ, Keshtgar M. Strategies for localisation of impalpable breast lesions. Breast. 2011;20:246–53. doi:10.1016/j.breast.2011.01.007.
Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014: Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2014;12:542–90.
Giammarile F, Alazraki N, Aarsvold JN, Audisio RA, Glass E, Grant SF, et al. Response to comment by Aprile et al.: the EANM and SNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer. Eur J Nucl Med Mol Imaging. 2014;41:1259–60. doi:10.1007/s00259-014-2750-6.
Sajid MS, Parampalli U, Haider Z, Bonomi R. Comparison of radioguided occult lesion localization (ROLL) and wire localization for non-palpable breast cancers: a meta-analysis. J Surg Oncol. 2012;105:852–8. doi:10.1002/jso.23016.
Nadeem R, Chagla LS, Harris O, Desmond S, Thind R, Titterrell C, et al. Occult breast lesions: a comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL). Breast. 2005;14:283–9. doi:10.1016/j.breast.2005.04.002.
Thind CR, Tan S, Desmond S, Harris O, Ramesh HS, Chagla L, et al. SNOLL. Sentinel node and occult (impalpable) lesion localization in breast cancer. Clin Radiol. 2011;66:833–9. doi:10.1016/j.crad.2011.02.017.
Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, et al. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer. 2005;104:20–9. doi:10.1002/cncr.21121.
Ahmed M, Douek M. Sentinel node and occult lesion localization (SNOLL): a systematic review. Breast. 2013;22:1034–40. doi:10.1016/j.breast.2013.09.007.
Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, et al. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology. Ann Surg Oncol. 2007;14:2928–31. doi:10.1245/s10434-007-9452-2.
Luini A, Zurrida S, Galimberti V, Paganelli G. Radioguided surgery of occult breast lesions. Eur J Cancer. 1998;34:204–5.
Philadelpho Arantes Pereira F1, Martins G, Gregorio Calas MJ, Fonseca Torres de Oliveira MV, Gasparetto EL, Barbosa da Fonseca LM. Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control. BMC Med Imaging. 2013;13:33. doi:10.1186/1471-2342-13-33.
Paredes P, Vidal-Sicart S, Zanon G, Roe N, Rubi S, Lafuente S, et al. Radioguided occult lesion localisation in breast cancer using an intraoperative portable gamma camera: first results. Eur J Nucl Med Mol Imaging. 2008;35:230–5. doi:10.1007/s00259-007-0640-x.
Bluemel C, Herrmann K, Kubler A, Buck AK, Geissinger E, Wild V, et al. Intraoperative 3-D imaging improves sentinel lymph node biopsy in oral cancer. Eur J Nucl Med Mol Imaging. 2014;41:2257–64. doi:10.1007/s00259-014-2870-z.
Kreienberg R, Albert US, Follmann M, Kopp IB, Kuhn T, Wockel A. Interdisciplinary GoR level III guidelines for the diagnosis, therapy and follow-up care of breast cancer: short version - AWMF registry no.: 032-045OL AWMF-register-nummer: 032-045OL - Kurzversion 3.0, Juli 2012. Geburtshilfe Frauenheilkd. 2013;73:556–83. doi:10.1055/s-0032-1328689.
Pouw B, de Wit-van der Veen LJ, van der Hage JA, Vrancken Peeters MJ, Wesseling J, Stokkel MP, et al. Radio-guided seed localization for breast cancer excision: an ex-vivo specimen-based study to establish the accuracy of a freehand-SPECT device in predicting resection margins. Nucl Med Commun. 2014;35:961–6. doi:10.1097/MNM.0000000000000159.
Lombardi A, Nigri G, Scopinaro F, Maggi S, Mattei M, Bonifacino A, et al. High-resolution, handheld camera use for occult breast lesion localization plus sentinel node biopsy (SNOLL): a single-institution experience with 186 patients. Surgeon. 2015;13:69–72. doi:10.1016/j.surge.2013.10.005.
Hindie E, Groheux D, Brenot-Rossi I, Rubello D, Moretti JL, Espie M. The sentinel node procedure in breast cancer: nuclear medicine as the starting point. J Nucl Med. 2011;52:405–14. doi:10.2967/jnumed.110.081711.
Bluemel C, Schnelzer A, Okur A, Ehlerding A, Paepke S, Scheidhauer K, et al. Freehand SPECT for image-guided sentinel lymph node biopsy in breast cancer. Eur J Nucl Med Mol Imaging. 2013;40:1656–61. doi:10.1007/s00259-013-2473-0.
Ahmed M, Douek M. Radioactive seed localisation (RSL) in the treatment of non-palpable breast cancers: systematic review and meta-analysis. Breast. 2013;22:383–8. doi:10.1016/j.breast.2013.04.016.
Postma EL, Verkooijen HM, van Esser S, Hobbelink MG, van der Schelling GP, Koelemij R, et al. Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial. Breast Cancer Res Treat. 2012;136:469–78. doi:10.1007/s10549-012-2225-z.
Mariscal Martinez A, Sola M, de Tudela AP, Julian JF, Fraile M, Vizcaya S, et al. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. AJR Am J Roentgenol. 2009;193:1001–9. doi:10.2214/AJR.08.2005.
Rampaul RS, Bagnall M, Burrell H, Pinder SE, Evans AJ, Macmillan RD. Randomized clinical trial comparing radioisotope occult lesion localization and wire-guided excision for biopsy of occult breast lesions. Br J Surg. 2004;91:1575–7. doi:10.1002/bjs.4801.
Pouw B, der Veen LJ, Hellingman D, Brouwer OR, Peeters MJ, Stokkel MP, et al. Feasibility of preoperative (125)I seed-guided tumoural tracer injection using freehand SPECT for sentinel lymph node mapping in non-palpable breast cancer. EJNMMI Res. 2014;4:19. doi:10.1186/s13550-014-0019-5.
Paganelli G, De Cicco C, Gatti G, Luini A. Radioguided occult lesion localziation in the breast. In: Mariani G, Giuliano AE, Strauss HW, editors. Radioguided surgery: a comprehensive team approach. New York: Springer; 2008. p. 226–32.
McGhan LJ, McKeever SC, Pockaj BA, Wasif N, Giurescu ME, Walton HA, et al. Radioactive seed localization for nonpalpable breast lesions: review of 1000 consecutive procedures at a single institution. Ann Surg Oncol. 2011;18:3096–101. doi:10.1245/s10434-011-1910-1.
Hargreaves AC, Mohamed M, Audisio RA. Intra-operative guidance: methods for achieving negative margins in breast conserving surgery. J Surg Oncol. 2014;110:21–5. doi:10.1002/jso.23645.
Compliance with ethical standards
Conflicts of interest
A.K.B. and K.H. are cofounders and shareholders of SurgicEye GmbH, Munich, Germany. C.B. had received a research grant from IZKF (Interdisziplinäres Zentrum für Klinische Forschung) Würzburg. All other authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 115 kb)
Rights and permissions
About this article
Cite this article
Bluemel, C., Cramer, A., Grossmann, C. et al. iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?. Eur J Nucl Med Mol Imaging 42, 1692–1699 (2015). https://doi.org/10.1007/s00259-015-3121-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-015-3121-7